Huaren Pharmaceuticals: Shareholder Huaren Century Group has reduced its holdings by 2.06%.

Huarui Pharmaceutical announced that its shareholder Huarui Century Group has completed the reduction plan. From December 5, 2025 to March 3, 2026, a total of 11.7097 million shares were reduced through centralized bidding, with an average price of 3.49 yuan per share, accounting for 0.99% of the company's total share capital. From December 5, 2025 to January 9, 2026, a total of 12.6551 million shares were reduced through block trades, with an average price of 2.96 yuan per share, accounting for 1.07%. The total reduction is 24.3648 million shares, accounting for 2.06%. After the reduction, their holdings are 57.1782 million shares, accounting for 4.84%, and the holding ratio has decreased to below 5%.